TLRY stock

Tilray Brands (TLRY) is a global lifestyle and consumer packaged goods company with operations in various sectors including beverage, cannabis, and wellness. The company's stock performance has been mixed, with several recent developments impacting its market position.

1. Stock Performance and Market Capitalization:
   • As of June 5, 2025, TLRY's closing price was $0.3904, with a market capitalization of $444.04 million.
   • The stock has faced challenges, as indicated by a 4.57% last change, which may reflect broader market trends or company-specific issues.

2. Partnerships and Product Launches:
   • Tilray Brands has extended its partnership with Zoo Atlanta for 18 years, showcasing a long-standing commitment to collaboration.
   • The company has launched a variety of craft beers, including the Pink Flamboyance Lager, which is a limited-edition brew that celebrates the partnership with Zoo Atlanta.
   • Tilray Beverages has highlighted several craft beers, including SweetWater Brewing's Dive Beer, which is a no-frills, all-chills lager perfect for summer.
3. New Product Offerings and Market Expansion:
   • Tilray Brands has introduced XMG Atomic Sours, a new line of cannabis beverages and gummies that redefine the sour experience.
   • The company's subsidiary, Revolver Brewing, has launched 'Y'all's Beer', a Texas-style lager targeting social gatherings and casual consumption occasions.
4. Financial Health and Stock Ratings:
   • Tilray Brands has been rated as a "Sell" by a quantitative model, which predicts poor future stock performance based on decelerating momentum and negative EPS revisions compared to other Health Care stocks.
   • The company has underperformed the S&P 500, with an average annual decline of 20% over the last 10 years for stocks rated Sell or worse.

In conclusion, Tilray Brands (TLRY) has been actively expanding its product portfolio and partnerships, which could positively influence its brand and market reach. However, the stock's performance is currently overshadowed by negative predictions from a quantitative model and past underperformance relative to the S&P 500. Investors should consider these factors along with broader market conditions and their investment goals before making decisions about TLRY stock.